Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor
J. YANG, C. M. Jablonowski, W. Quarni, S. Singh, H. Tan, D. H. Bostanthirige, H. Jin, J. Fang, T.-C. Chang, D. Finkelstein, J.-H. Cho, D. Hu, V. Pagala, S. M. Sakurada, S. M. Pruett-Miller, , G. Wu
This study shows JMJD6 links pre-mRNA splicing and metabolism in MYC-driven cancers, and its inhibition enhances therapeutic response to splicing inhibitors.
bioRxiv · Jun 26, 2023Cancer Biology